TY - JOUR
T1 - Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia
AU - Schumacher, Frances-Rose
AU - Siew, Keith
AU - Zhang, Jinwei
AU - Johnson, Clare
AU - Wood, Nicola
AU - Cleary, Sarah E
AU - Al Maskari, Raya S
AU - Ferryman, James T
AU - Hardege, Iris
AU - Yasmin, [No Value]
AU - Figg, Nichola L
AU - Enchev, Radoslav
AU - Knebel, Axel
AU - O'Shaughnessy, Kevin M
AU - Kurz, Thimo
N1 - © 2015 The Authors. Published under the terms of the CC BY 4.0 license.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Deletion of exon 9 from Cullin-3 (CUL3, residues 403-459: CUL3Δ403-459) causes pseudohypoaldosteronism type IIE (PHA2E), a severe form of familial hyperkalaemia and hypertension (FHHt). CUL3 binds the RING protein RBX1 and various substrate adaptors to form Cullin-RING-ubiquitin-ligase complexes. Bound to KLHL3, CUL3-RBX1 ubiquitylates WNK kinases, promoting their ubiquitin-mediated proteasomal degradation. Since WNK kinases activate Na/Cl co-transporters to promote salt retention, CUL3 regulates blood pressure. Mutations in both KLHL3 and WNK kinases cause PHA2 by disrupting Cullin-RING-ligase formation. We report here that the PHA2E mutant, CUL3Δ403-459, is severely compromised in its ability to ubiquitylate WNKs, possibly due to altered structural flexibility. Instead, CUL3Δ403-459 auto-ubiquitylates and loses interaction with two important Cullin regulators: the COP9-signalosome and CAND1. A novel knock-in mouse model of CUL3WTΔ403-459 closely recapitulates the human PHA2E phenotype. These mice also show changes in the arterial pulse waveform, suggesting a vascular contribution to their hypertension not reported in previous FHHt models. These findings may explain the severity of the FHHt phenotype caused by CUL3 mutations compared to those reported in KLHL3 or WNK kinases.
AB - Deletion of exon 9 from Cullin-3 (CUL3, residues 403-459: CUL3Δ403-459) causes pseudohypoaldosteronism type IIE (PHA2E), a severe form of familial hyperkalaemia and hypertension (FHHt). CUL3 binds the RING protein RBX1 and various substrate adaptors to form Cullin-RING-ubiquitin-ligase complexes. Bound to KLHL3, CUL3-RBX1 ubiquitylates WNK kinases, promoting their ubiquitin-mediated proteasomal degradation. Since WNK kinases activate Na/Cl co-transporters to promote salt retention, CUL3 regulates blood pressure. Mutations in both KLHL3 and WNK kinases cause PHA2 by disrupting Cullin-RING-ligase formation. We report here that the PHA2E mutant, CUL3Δ403-459, is severely compromised in its ability to ubiquitylate WNKs, possibly due to altered structural flexibility. Instead, CUL3Δ403-459 auto-ubiquitylates and loses interaction with two important Cullin regulators: the COP9-signalosome and CAND1. A novel knock-in mouse model of CUL3WTΔ403-459 closely recapitulates the human PHA2E phenotype. These mice also show changes in the arterial pulse waveform, suggesting a vascular contribution to their hypertension not reported in previous FHHt models. These findings may explain the severity of the FHHt phenotype caused by CUL3 mutations compared to those reported in KLHL3 or WNK kinases.
KW - CUL3
KW - Cullin
KW - Monogenic hypertension syndromes
KW - Proteasome
KW - Ubiquitin
KW - WNK/SPAK/OSR1 pathway
UR - http://www.scopus.com/inward/record.url?scp=84939502546&partnerID=8YFLogxK
U2 - 10.15252/emmm.201505444
DO - 10.15252/emmm.201505444
M3 - Article
C2 - 26286618
AN - SCOPUS:84942831685
SN - 1757-4676
VL - 7
SP - 1285
EP - 1306
JO - EMBO Molecular Medicine
JF - EMBO Molecular Medicine
IS - 10
ER -